During the past decade, Toronto Heart Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto Heart Centre" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Toronto Heart Centre" are "Heart Failure" (2 trials), "Amyloid Cardiomyopathy" (1 trials), "Amyloidosis" (1 trials), "Cardiomyopathies" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "Toronto Heart Centre" in a lesser frequency.

Most popular intervention types in "Toronto Heart Centre" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Acoramidis (AG10)" (1 trials), "Placebo Oral Tablet" (1 trials) and "acoramidis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Toronto Heart Centre" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Toronto Heart Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Toronto Heart Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Toronto Heart Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".